| 영문 | family therapy | 한글 | 가족요법 |
|---|---|---|---|
| 설명 | 가족을 치료 대상으로 하는 심리요법 중의 하나. 가족중의 문제는 문제를 가진 개인만이 아니라 문제 가족을 대상으로 해결해 나갈 필요가 있다는 인식을 바탕으로 하여 가족 전체의 심리적 성숙을 목표로 한 요법이다. 크게 나누어 가족 중의 특정인을 대상으로 하여 각각 다른 독립된 치료를 하는 병행심리요법과 가족 전체를 동시 면접하는 방법을 주로 하는 합동가족요법이 있는데, 특히 후자를 가리켜 가족요법 이라고 하는 경우가 많다. |
||
| 영문 | intracavitary therapy | 한글 | 강내요법 |
|---|---|---|---|
| 설명 | 체강내, 즉 입안, 코안, 인두강, 식도, 곧창자, 질, 자궁목, 방광 등의 내강에, 때로는 병터에 의해 생긴 공동내에 방사선을 삽입해서 치료하는 것을 말한다. 주로 종양의 치료를 목적으로 한다. |
||
| 영문 | hyperbaric oxygenation therapy | 한글 | 고압산소요법 |
|---|---|---|---|
| 설명 | 대기압보다 높은 기압환경을 인공적으로 만들어 그 안에서 고농도의 산소를 흡입시키는 요법. 한국에서 연탄가스로 대표되는 일산화탄소의 급성중독의 치료에 많이 이용된 것으로, 보통 3대기압 정도로 가압된 고압산소실이나 고압산소탱크 속에 환자를 놓고 전신에 산소를 흡입시킨다. 고압실은 크고 작은 여러 가지가 있으며, 구조상 1실식-2실식-다실식이 있다. 가압 가스의 종류에는 산소-공기-혼합 가스등이 있고, 2~3 대기압 또는 그 이상의 고압 환경을 만든다. 임상적으로 응용범위가 넓어서 기계적 효과에 의하여 잠수부병이나 창자관마비에 의한 창자폐색 치료 등에 유효하고, 가스궤저 등의 무산소성 세균감염에서도 이용된다. 또 산소운반효과에 의하여 일산화탄소-심근경색-뇌색전증-출혈쇼크에 의한 급성의 조직산소결핍의 치료에 유효하다. 또 암의 방사선요법에 병용하면 이 요법으로 암세포의 분열이 왕성해져, 세포분열 중인 세포에 방사선을 조사함으로써 분열능력을 없애는 데 유효하여 고압산소흡입조사법이라고 한다. |
||
| 영문 | interstitial therapy | 한글 | 근접치료 |
|---|---|---|---|
| 설명 | 주로 종양의 치료를 목적으로 하여 인체 조직내에 방사선 물질을 삽입하여 방사선을 조사하는 치료법이다. Brachytherapy라고도 한다. |
||
| 영문 | symptomatic therapy | 한글 | 대증요법 |
|---|---|---|---|
| 설명 | 병의 원인을 찾아 없애기 곤란한 상황에서, 겉으로 나타난 병의 증상에 대응하여 처치를 하는 치료법. 열이 높을 때에 얼음주머니를 대거나 해열제를 써서 열을 내리게 하는 따위가 이에 속한다. |
||
| DOPA, dopa | dihydroxyphenylalanine |
|---|---|
| L-DOPA, | L-dopa levodopa, levo-3, 4-dihydroxyphenylalanine |
| CT | calcitonin; calf testis; cardiac tamponade; cardiothoracic [ratio]; carotid tracing; carpal tunnel; ... |
| IT | immunological test; immunotherapy; implantation test; individual therapy; information technology; in... |
| MT | magnetization transfer; malaria therapy; malignant teratoma; mammary tumor; mammilothalamic tract; m... |
| (18)F-DOPA | 6-[(18)F]fluoro-L-DOPA |
|---|---|
| L-DOPA | L-Dihydroxphenylalanine |
| 6-FD | 18F]6-fluoro-L-dopa |
| DOPA | 3,4-dihydrophenylalanine |
| DA | DOPA and dopamine |
methyl group
| alpha methyl dopa | <drug> An antihypertensive drug, preferred in pregnant patients. (18 Nov 1997) |
|---|---|
| decarboxylated dopa | <drug> A catecholamine neurotransmitter and hormone (153 D), formed by decarboxylation of dehydroxyphenylalanine (dopa). A precursor of adrenaline and noradrenaline. Pharmacologic action: 1. Precursor of norepinephrine 2. Stimulates dopaminergic, alpha and beta-1 adrenergic receptors: 3. Dopaminergic (1-2 mcg/kg per min): cerebral, renal, and mesenteric vasodilation increase urine output 4. Mixed alpha and beta-1 (2-10 mcg/kg per min): increases cardiac ouput with moderate increase systemic vascular resistance 5. Predominantly alpha (>20 mcg/kg per min): increases systemic vascular resistance Uses: 1. Treat hypotension associated with bradycardia 2. Stimulate cardiac output and urine output Dose: 1. Start infusion at 1-5 mcg/kg per min and titrate to effect. 2. Use the lowest dose that provides the desired hemodynamic improvement. 3. Do not exceed 20 mcg/kg per min. Potential complications: 1. May increase pulmonary pressure and worsen pulmonary congestion. 2. May increase myocardial work without improving coronary blood flow, exacerbating myocardial ischemia 3. Stimulates heart rate and may cause supraventricular or ventricular arrhythmias (15 Mar 2000) |
| dopa | An amino acid derived from the amino acid tyrosine. It is formed as the first intermediate in the production of dopamine, a neurotransmitter. (09 Oct 1997) |
| dopa decarboxylase | <enzyme> One of the aromatic-l-amino-acid decarboxylases, this enzyme is responsible for the conversion of dopa to dopamine. It is of clinical importance in the treatment of parkinson's disease. Registry number: EC 4.1.1.- (12 Dec 1998) |
| DOPA dioxygenase | <enzyme> Key enzyme in betalain biosynthesis pathway of amanita muscaria; genbank y12886 Registry number: EC 1.14.99.- Synonym: dopa-4,5-dioxygenase, doda gene product (26 Jun 1999) |
| dopa oxidase | Provisional name given the enzyme(s) catalyzing the formation of melanins from dopa; it now appears that the copper-containing monophenol monooxygenases and/or catechol oxidases are responsible for the oxidation of l-tyrosine to dopa and dopa quinone. (05 Mar 2000) |
| dopa quinone | An oxidation product of dopa and an intermediate in the formation of melanin from tyrosine. (05 Mar 2000) |
| dopa reaction | A dark staining observed in fresh tissue sections to which a solution of dopa has been applied, presumably due to the presence of dopa oxidase in the protoplasm of certain cells. Synonym: Bloch's reaction. (05 Mar 2000) |
| dopa-responsive dystonia | A condition successfully treated with drugs. Typically, DRD begins in childhood or adolescence with progressive difficulty in walking and, in some cases, spasticity. Segawa's dystonia is an important variant of DRD. In Segawa's dystonia, the symptoms fluctuate during the day from relative mobility in the morning to increasingly worse disability in the afternoon and evening as well as after exercise. Some scientists feel DRD is not only rare but also rarely diagnosed since it mimics many of the symptoms of cerebral palsy. (12 Dec 1998) |
| Dopa-tyrosine sulfotransferase | <enzyme> Active towards tyrosine and dopa isomers except dl-ortho-tyrosine; isolated from rat liver; genbank u38419 Registry number: EC 2.8.2.- (26 Jun 1999) |
| dystonia, dopa-responsive | A condition successfully treated with drugs. Typically, DRD begins in childhood or adolescence with progressive difficulty in walking and, in some cases, spasticity. Segawa's dystonia is an important variant of DRD. In Segawa's dystonia, the symptoms fluctuate during the day from relative mobility in the morning to increasingly worse disability in the afternoon and evening as well as after exercise. Some scientists feel DRD is not only rare but also rarely diagnosed since it mimics many of the symptoms of cerebral palsy. (12 Dec 1998) |
| l-dopa | <chemical> The naturally occurring form of dopa and the immediate precursor of dopamine. Unlike dopamine itself, it can be taken orally and crosses the blood-brain barrier. It is rapidly taken up by dopaminergic neurons and converted to dopamine. It is used for the treatment of parkinsonism and is usually given with agents that inhibit its conversion to dopamine outside of the central nervous system. Pharmacological action: antiparkinson agents, dopamine agents. (12 Dec 1998) |
| L-dopa peroxidase | <enzyme> Found in human erythrocytes associated with catalase Registry number: EC 1.11.- (26 Jun 1999) |
| active methyl | A methyl group attached to a quaternary ammonium ion or a tertiary sulfonium ion that can take part in transmethylation reactions; e.g., methyl groups in choline and in S-adenosyl-l-methionine, which are thus methyl donors. (05 Mar 2000) |
| aklanonic acid methyl ester cyclase | <enzyme> Catalyses the formation of aklaviketone from aklanonic acid methyl ester; involved in daunomycin biosynthesis; see also daunorubicin-doxorubicin polyketide synthase Registry number: EC 5.- Synonym: aame cyclase, daud protein, daud gene product, dnrd protein, dnrd gene product (26 Jun 1999) |
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|